JESSICA HOSKINS: Open Payments
NPI 1467834507 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 35 payments from 9 companies in 2025. Trend: 2023 $101 · 2024 $679 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| MDD US Operations, LLC | 17 | $154 |
| ABBVIE INC. | 5 | $113 |
| ACADIA Pharmaceuticals Inc | 3 | $64 |
| Amneal Pharmaceuticals LLC | 2 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $35 |
| Merz Pharmaceuticals, LLC | 1 | $26 |
| Lundbeck LLC | 1 | $19 |
Products named: VYALEV, REXULTI, NUPLAZID, Apokyn, CREXONT, Xadago, AUSTEDO XR, AMYVID.
Industry payments across NC — which companies pay providers there.
